NON-ST-Segment Elevation Myocardial Infarction Associated with Inadvertent Thyroid Hormone Overdose

Andrew V. Doodnauth¹, Fadi Yacoub¹, Vaibhavi Solanki¹, Andrea Trimmingham¹, Lina Soni¹ and Samy I. McFarlane^1,

¹Department of Internal Medicine, State University of New York: Downstate Medical Center, Brooklyn, New York, United States- 11203

Cite this paper

Andrew V. Doodnauth, Fadi Yacoub, Vaibhavi Solanki, Andrea Trimmingham, Lina Soni and Samy I. McFarlane. NON-ST-Segment Elevation Myocardial Infarction Associated with Inadvertent Thyroid Hormone Overdose. American Journal of Medical Case Reports. 2021; 9(3):194-197. doi: 10.12691/AJMCR-9-3-15

Abstract

Thyroid hormone has a major role in cardiovascular function and cardiac hemodynamics. A slight change in thyroid affects ventricular function, serum cholesterol levels, increases the risk of coronary artery disease as well as cardiovascular mortality. In this report, we present a 62-year-old female with history significant for ischemic heart disease who was admitted for acute coronary syndrome (ACS) with persistent tachycardia, requiring urgent cardiac catheterization. Complete cardiac workup revealed that the patient had most likely suffered from vasospastic angina secondary to inadvertent overdose of her prescribed levothyroxine. This report emphasizes the significant cardiac complications caused by a deluged hyperadrenergic state secondary to overt hyperthyroidism. We conclude that thyrotoxicosis is a significant risk factor for cardiovascular disease and should be considered as a cause of life-threatening myocardial ischemia, especially in patients with known ischemic heart disease and thyroid disorders.

Keywords

thyroid hormone, ischemic heart disease, acute coronary syndrome, levothyroxine, hyperthyroidism, cardiovascular disease

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001 Feb 15; 344(7): 501-9.
[2]	De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016 Aug 27; 388(10047): 906-918.
[3]	Zeitjian V, Moazez C, Saririan M, August DL, Roy R. Manifestation of non-ST elevation myocardial infarction due to hyperthyroidism in an anomalous right coronary artery. Int J Gen Med. 2017 Nov 8; 10: 409-413.
[4]	Osuna PM, Udovcic M, Sharma MD. Hyperthyroidism and the Heart. Methodist Debakey Cardiovasc J. 2017 Apr-Jun; 13(2): 60-63.
[5]	Stamate CS, Andronescu AM, Nechita AC, Delcea C, Mihu EM, Vintila MM. Physiopathological aspects of the subclinical alterations of thyroid function associated with acute coronary syndromes. J Med Life. 2013; 6(4): 409-13.
[6]	Masani ND, Northridge DB, Hall RJ. Severe coronary vasospasm associated with hyperthyroidism causing myocardial infarction. Br Heart J. 1995 Dec; 74(6): 700-1.
[7]	Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001 Feb 15; 344(7): 501-9.